A Phase II Study of Nelfinavir plus Concurrent Chemoradiation for Advanced, HPV-Negative Squamous Cell Carcinoma of the Head and Neck

被引：0
|
作者：
Su, W. [1 ]
Maity, A. [2 ]
Pryma, D. A. [3 ]
Mankoff, D. [4 ]
Cohen, R. [5 ]
Lukens, J. N. [2 ]
Lin, A. [2 ]
机构：
[1] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Univ Penn, Div Hematol & Oncol, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1077
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [21] Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck
    Aguilar-Ponce, JL
    Granados-García, M
    Villavicencio, V
    Poitevin-Chacón, A
    Green, D
    Dueñas-González, A
    Herrera-Gómez, A
    Luna-Ortiz, K
    Alvarado, A
    Martínez-Said, H
    Castillo-Henkel, C
    Segura-Pacheco, B
    De la Garza, J
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 301 - 306
  • [22] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [23] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [24] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [25] A phase II study of nimotuzumab and CDDP concurrent with radiation in locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Lim, Wan-Teck
    Ang, Mei-Kim
    Quan Sing Ng
    Wang, Lan-Ying
    Chau, Noan-Minh
    Tan, Daniel S. W.
    Chay, Wen Yee
    Leong, Swan
    Tan, Eng-Huat
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Immunotherapy for HPV negative head and neck squamous cell carcinoma
    Jiang, Binyumeng
    Elkashif, Ahmed
    Coulter, Jonathan A.
    Dunne, Nicholas J.
    Mccarthy, Helen O.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (05):
  • [27] The Addition of Docetaxel to Platinum Based Concurrent Chemoradiation Improves the Response and Survival in Patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck; Phase II Study
    Rayan, Amal
    Shehata, Samir
    Aboshanif, Mohamed Modather
    Aleem, Doaa Abdel
    El-Naggar, Maha Salah
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2024, 8 (01): : 49 - 58
  • [28] Concurrent chemoradiation therapy for advanced head and neck squamous cell carcinoma (HNSCC) in a community hospital.
    Levine, MA
    Saunders, JR
    Zinreich, E
    Kunar, D
    Price, J
    Hirata, RM
    Williams, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 502S - 502S
  • [29] Results from a pilot study of nimotuzumab with concurrent chemoradiation in patients with locally advanced squamous cell carcinoma of head and neck
    Gupta, M.
    Madholia, V.
    Gupta, N.
    Bhowmik, K. T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [30] NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma
    Topchu, Iuliia
    Bychkov, Igor
    Gursel, Demirkan
    Makhov, Petr
    Boumber, Yanis
    CELL DEATH DISCOVERY, 2024, 10 (01)
12345